# Shotsy Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shotsy

- Industry: Software
- Headquarters: US
- Website: www.shotsyapp.com
- Total disclosed funding: $2.3M
- Latest round: Seed (Feb 13, 2025)
- Investors on record: 2

## About

Shotsy Co. is a health technology company specializing in a tracking application tailored for users of GLP-1 medications, enabling efficient management of medication schedules and health metrics.Shotsy Co. is a developer of a specialized tracking application designed for users of GLP-1 medications. The firm was founded in the US and has completed a single deal as of February 13, 2025. The company successfully raised USD 2.25 mn in Seed funding led by Coalition Operators and Springbank Collective. The founder's specific history is not detailed publicly.Shotsy is a specialized tracking application designed for users of GLP-1 medications, such as Ozempic®, Mounjaro®, Wegovy®, and Zepbound®. The app enables users to log their weekly injections, monitor side effects, and track various health metrics including weight, protein intake, water consumption, and calorie count. By consolidating these functions into a single platform, Shotsy addresses the needs of individuals managing treatments for type 2 diabetes and obesity, providing a streamlined approach to health tracking. Its primary user base comprises patients who are beginning their GLP-1 treatment journey or seeking to optimize their ongoing progress. The application is available to users in various geographical markets, including the United States, Canada, and parts of Europe, aligning with the increasing global adoption of GLP-1 therapies.Shotsy generates revenue through a subscription-based model that allows users to access premium features of the app. This model typically entails a monthly or annual subscription fee, providing users with enhanced capabilities such as advanced analytics and personalized tracking options. The transactional structure centers around direct-to-consumer sales, where individuals subscribe directly via the app. The flagship offerings include the core tracking functionalities, which help users manage their medication schedules and health metrics effectively. Additionally, partnerships with healthcare providers may facilitate referrals, further expanding the app's reach within its target market.In February 2025, Shotsy Co. raised USD 2.25 mn in Seed funding, which will be utilized to expand into new markets. The company is focused on launching additional features and enhancing its application, though specific new products and release dates have not yet been disclosed. Plans for geographic expansion include targeting additional regions in North America and Europe within the next 12 to 18 months.

## Funding rounds

- Seed, Feb 13, 2025, $2.3M — Springbank Collective, Coalition Operators

## Investors

- Springbank Collective (https://capitalatlas.ai/funds/springbank-collective) — Seed
- Coalition Operators (https://capitalatlas.ai/funds/coalition-operators) — Seed